Artelo Biosciences
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-10.33-12.6613.174.98
Price/Sales ratio
N/AN/A8.364.50
Earnings per Share (EPS)
$-0.94$-0.77$0.74$1.95

Historical Multiples (2014 – 2022)

2014 2015 2016 2017 2018 2019 2020 2021 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
-114.20-291.36-148.00-21.38-2.50-1.93-0.76-2.28-0.82-0.51-11.94
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
118.37290.43-318.429.21-43.400.770.911.410.420.38-17.09
Price/Cash Flow ratio
-114.20-328.89-237.66-23.16-3.63-1.50-0.81-2.77-1.02-0.73-13.40
Price/Free Cash Flow ratio
-114.20-328.89-237.66-23.16-3.63-0.98-0.81-2.77-1.02-0.73-13.39
Price/Earnings Growth ratio
N/A4.85-1.54-0.03-0.000.04-0.020.030.010.00-0.01
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
N/AN/AN/AN/A-0.00%94.07%1.29%0.05%2.07%N/A-0.00%
Return on Assets
-103.65%-89.50%-827.01%-40.90%-590.30%-33.50%-106.35%-58.86%-48.34%-70.98%-315.60%
Return On Equity
-103.65%-99.67%215.14%-43.11%1736.25%-39.77%-120.13%-61.75%-50.88%-63.77%848.23%
Return on Capital Employed
-103.65%-99.67%215.14%-42.72%1736.25%-58.76%-120.93%-61.45%-52.95%-75.69%838.74%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/A0.744.344.65N/AN/A18.359.55
Quick Ratio
N/A9.790.2019.500.744.354.6519.6118.3516.0710.12
Cash ratio
N/A9.790.2019.450.634.334.2612.606.906.9010.04
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/AN/A0.000.000.04N/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/AN/A0.000.000.05N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/A0.000.000.00N/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/A0.000.000.00N/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A-2.94KN/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/AN/A-64.64-127.11-160.33N/A
Company Equity Multiplier
11.11-0.261.05-2.941.181.121.041.051.05-0.94
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
11111.001.5311111.26
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/AN/A-64.64-127.11-160.33N/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/A-219.32-200.2-252.52N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A